Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis
Yi, J.S, Guidon, A, Sparks, S, Osborne, R, Juel, V.C, Massey, J.M, Sanders, D.B, Weinhold, K.J, Guptill, J.T
Published in Journal of autoimmunity (01.08.2014)
Published in Journal of autoimmunity (01.08.2014)
Get full text
Journal Article
Impact of Concurrent Chemoradiation on T Cell Populations in Patients With Advanced-Stage Oropharyngeal Squamous Cell Carcinoma
Lee, W.T, Medinas, R, Lee, J.H, Sparks, S, Brizel, D.M, Esclamado, R.M, Ready, N, Weinhold, K.J
Published in International journal of radiation oncology, biology, physics (01.02.2014)
Published in International journal of radiation oncology, biology, physics (01.02.2014)
Get full text
Journal Article
Polyfunctional Cytomegalovirus‐Specific Immunity in Lung Transplant Recipients Receiving Valganciclovir Prophylaxis
Snyder, L. D., Medinas, R., Chan, C., Sparks, S., Davis, W. A, Palmer, S. M., Weinhold, K. J.
Published in American journal of transplantation (01.03.2011)
Published in American journal of transplantation (01.03.2011)
Get full text
Journal Article
Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults
Mulligan, M J, Russell, N D, Celum, C, Kahn, J, Noonan, E, Montefiori, D C, Ferrari, G, Weinhold, K J, Smith, J M, Amara, R R, Robinson, H L
Published in AIDS research and human retroviruses (01.07.2006)
Published in AIDS research and human retroviruses (01.07.2006)
Get more information
Journal Article
Replication-defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiency virus-1 cytotoxic T lymphocytes present in infected patients : Implications for antigen-specific immunotherapy
FERRARI, G, BEREND, C, WEINHOLD, K. J, OTTINGER, J, DODGE, R, BARTLETT, J, TOSO, J, MOODY, D, TARTAGLIA, J, COX, W. I, PAOLETTI, E
Published in Blood (15.09.1997)
Published in Blood (15.09.1997)
Get full text
Journal Article
Replication-Defective Canarypox (ALVAC) Vectors Effectively Activate Anti–Human Immunodeficiency Virus-1 Cytotoxic T Lymphocytes Present in Infected Patients: Implications for Antigen-Specific Immunotherapy
Ferrari, G., Berend, C., Ottinger, J., Dodge, R., Bartlett, J., Toso, J., Moody, D., Tartaglia, J., Cox, William I., Paoletti, E., Weinhold, K.J.
Published in Blood (15.09.1997)
Published in Blood (15.09.1997)
Get full text
Journal Article